Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lantheus Holdings, Inc.

NASDAQ: LNTH · Life Sciences · 7 alerts · CIK 1521036

Share price
$101.72Close, Nov 16
Market cap
$6.65B
Shares outstanding
65.4MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lantheus Holdings, Inc. filings on SEC EDGAR ↗

7:52 AM ET 10-Q
Financial Results

Lantheus Holdings Q3 2026 Results: Net Income $22.4M, Down 19.4% YoY

Lantheus Holdings reported net income of $215.8 million for the nine months ended September 30, 2026, compared to $179.5 million in the prior year period. The company saw a significant increase in cash and cash equivalents to $683.6 million, bolstered by a $59.4 million gain on the sale of a business.

Key figure
Net income $22.4M · -19.4% YoY
7:41 AM ET 8-K
Financial Results

Lantheus Holdings Financial Results

Lantheus Holdings reported Q3 2026 financial results with worldwide revenue of $389.9 million and adjusted EPS of $1.68. The company also highlighted the pending $8.0 billion acquisition by Curium and the recent FDA approvals of TAUKLARIFY and BRAVNETSA. Due to the pending merger, the company has suspended its full-year 2026 financial guidance.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.